BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28778710)

  • 1. How I treat patients with systemic sclerosis in clinical practice.
    Rossi D; Zanatta E; Marson P; Sciascia S; Polito P; Roccatello D; Cozzi F
    Autoimmun Rev; 2017 Oct; 16(10):1024-1028. PubMed ID: 28778710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models of systemic sclerosis.
    Morin F; Kavian N; Batteux F
    Curr Pharm Des; 2015; 21(18):2365-79. PubMed ID: 25777753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based management of systemic sclerosis: Navigating recommendations and guidelines.
    Pellar RE; Pope JE
    Semin Arthritis Rheum; 2017 Jun; 46(6):767-774. PubMed ID: 28088339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of systemic sclerosis-current concept and emerging treatments.
    Furue M; Mitoma C; Mitoma H; Tsuji G; Chiba T; Nakahara T; Uchi H; Kadono T
    Immunol Res; 2017 Aug; 65(4):790-797. PubMed ID: 28488090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of platelets in autoimmunity, vasculopathy, and fibrosis: Implications for systemic sclerosis.
    Ntelis K; Solomou EE; Sakkas L; Liossis SN; Daoussis D
    Semin Arthritis Rheum; 2017 Dec; 47(3):409-417. PubMed ID: 28602360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting interferons as a strategy for systemic sclerosis treatment.
    Ciechomska M; Skalska U
    Immunol Lett; 2018 Mar; 195():45-54. PubMed ID: 29106987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategy for treatment of fibrosis in systemic sclerosis: Present and future.
    Yanaba K
    J Dermatol; 2016 Jan; 43(1):46-55. PubMed ID: 26782006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic sclerosis.
    Denton CP; Khanna D
    Lancet; 2017 Oct; 390(10103):1685-1699. PubMed ID: 28413064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early inflammatory players in cutanous fibrosis.
    Raker V; Haub J; Stojanovic A; Cerwenka A; Schuppan D; Steinbrink K
    J Dermatol Sci; 2017 Sep; 87(3):228-235. PubMed ID: 28655471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review.
    Mostmans Y; Cutolo M; Giddelo C; Decuman S; Melsens K; Declercq H; Vandecasteele E; De Keyser F; Distler O; Gutermuth J; Smith V
    Autoimmun Rev; 2017 Aug; 16(8):774-786. PubMed ID: 28572048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
    Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF
    Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course.
    Becker MO; Riemekasten G
    Expert Rev Clin Immunol; 2016; 12(2):115-35. PubMed ID: 26558747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic sclerosis: a prototypic multisystem fibrotic disorder.
    Varga J; Abraham D
    J Clin Invest; 2007 Mar; 117(3):557-67. PubMed ID: 17332883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One year in review 2019: systemic sclerosis.
    Barsotti S; Orlandi M; Codullo V; Di Battista M; Lepri G; Della Rossa A; Guiducci S
    Clin Exp Rheumatol; 2019; 37 Suppl 119(4):3-14. PubMed ID: 31587697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasculopathy in scleroderma.
    Asano Y; Sato S
    Semin Immunopathol; 2015 Sep; 37(5):489-500. PubMed ID: 26152638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of functional autoantibodies against vascular receptors in systemic sclerosis.
    Riemekasten G; Philippe A; Näther M; Slowinski T; Müller DN; Heidecke H; Matucci-Cerinic M; Czirják L; Lukitsch I; Becker M; Kill A; van Laar JM; Catar R; Luft FC; Burmester GR; Hegner B; Dragun D
    Ann Rheum Dis; 2011 Mar; 70(3):530-6. PubMed ID: 21081526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical Appraisal of the Utility and Limitations of Animal Models of Scleroderma.
    Tsujino K; Sheppard D
    Curr Rheumatol Rep; 2016 Jan; 18(1):4. PubMed ID: 26711695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic sclerosis.
    Asano Y
    J Dermatol; 2018 Feb; 45(2):128-138. PubMed ID: 29226387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature.
    Giuggioli D; Lumetti F; Colaci M; Fallahi P; Antonelli A; Ferri C
    Autoimmun Rev; 2015 Nov; 14(11):1072-8. PubMed ID: 26209905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on systemic sclerosis.
    McCray CJ; Mayes MD
    Curr Allergy Asthma Rep; 2015 May; 15(5):25. PubMed ID: 26139334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.